Working to better understand infectious diseases, the University of New Mexico is joining with DeCode Genetics Inc. and the National Center for Genome Resources in a five-year research agreement. (BioWorld Today)
Eight months after receiving approval for Erbitux in colorectal cancer, ImClone Systems Inc. and Bristol-Myers Squibb Co. set out on another Phase III program for the drug, this time targeting non-small-cell lung cancer. (BioWorld Today)
